[1]
A. Nowak, J. Jarosz-Popek, and M. Postuła, “Patient with hypertension, metabolic disorder and benign prostatic hyperplasia in the primary care physician’s office – the role of doxazosin”, J EBM, vol. 14, no. 3(52), pp. 269-273, Sep. 2021.